Business

Press Release Mar 30 2026

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release -"Wockhardt's Zaynich® (Zidebactam/Cefepime) Receives Favourable Recommendation from CDSCO's Subject Expert Committee for Treatment of Gram-Negative Infections".

articleWockhardt LimitedMarch 30, 20263/news/press-release-mar-30-2026-4
Press Release Mar 30 2026

About this update from Wockhardt Limited

Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release -"Wockhardt's Zaynich® (Zidebactam/Cefepime) Receives Favourable Recommendation from CDSCO's Subject Expert Committee for Treatment of Gram-Negative Infections". View Attachment

View stock analysis, news, and events for Wockhardt Limited